When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
SPECT and PET in ischemic heart failure
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction
Nitrosative stress drives heart failure with preserved ejection fraction
Ambulatory Inotrope Infusions in Advanced Heart Failure - A Systematic Review and Meta-Analysis
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)